|Videos|December 6, 2022
Regulatory Considerations for Cell & Gene Therapies
Author(s)PPD
The first segment of this five-part PPD Tech Talk series on A CMC Roadmap for Cell and Gene Therapies, Katherine Hanson, Ph.D., associate director at PPD Laboratory services, GMP Lab, discusses regulatory considerations for cell and gene therapies.
Related Content
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
3
Lonza Increases HPAPI Production at Visp Facility
4
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
5